{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/conjunctivitis-allergic/diagnosis/assessment/","result":{"pageContext":{"chapter":{"id":"089d5cf7-0f6b-521b-88c1-d4f25eef7101","slug":"assessment","fullItemName":"Assessment","depth":2,"htmlHeader":"<!-- begin field c1134d0b-82ff-4441-9a69-27577732788e --><h2>How do I assess a person with suspected allergic conjunctivitis?</h2><!-- end field c1134d0b-82ff-4441-9a69-27577732788e -->","summary":"","htmlStringContent":"<!-- begin item 485c683a-6e37-4093-a68c-15b37ac7ec05 --><!-- begin field ea2d6939-3424-4606-a073-206d9236f542 --><p>Assess all people presenting with a unilateral red eye for features indicating a serious and potentially sight-threatening cause (such as acute glaucoma, corneal ulcer, anterior uveitis, scleritis, or trauma) — for further information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/red-eye/\">Red eye</a>.</p><p><strong>Take a history asking about:</strong></p><ul><li>Onset and duration of symptoms.</li><li><a class=\"topic-reference internal-reference\" href=\"/topics/conjunctivitis-allergic/diagnosis/clinical-features/\">Clinical features</a> including:<ul><li>Variation of symptoms with location, season and exposure to specific triggers and whether symptoms are unilateral or bilateral.</li><li>Amount and type (watery, purulent, or mucopurulent) of discharge and when it is worst (for example on waking from sleep).</li><li>Itching.<ul><li>Ask about severity of itch and if it is intermittent or persistent — if severe itching is present consider serious allergic ocular conditions such as <a class=\"topic-reference internal-reference\" href=\"/topics/conjunctivitis-allergic/background-information/definition/\">vernal keratoconjunctivitis</a> and <a class=\"topic-reference internal-reference\" href=\"/topics/conjunctivitis-allergic/background-information/definition/\">atopic keratoconjunctivitis</a>.</li></ul></li><li>Changes in vision such as blurring.</li><li>Eyelid changes such as swelling and flaking.</li></ul></li><li>Recent exposure to a person with similar symptoms.</li><li>Red flags indicating the need for <a class=\"topic-reference internal-reference\" href=\"/topics/conjunctivitis-allergic/management/referral/#who-should-i-refer\">urgent ophthalmology assessment</a> such as:<ul><li>Reduced visual acuity.</li><li>Marked eye pain, headache or photophobia — always consider serious systemic conditions such as meningitis in a person presenting with photophobia.</li><li>Inability to open the eye or keep it open.</li><li>Red sticky eye in a neonate (within 30 days of birth).</li><li>History of trauma (mechanical, chemical or ultraviolet) or possible foreign body.</li><li>Copious rapidly progressive discharge — may indicate gonococcal infection.</li><li>Possible infection with a herpes virus:<ul><li><em>Herpes simplex</em> — may present as unilateral red eye with vesicular lesions on the eyelid.</li><li><em>Herpes zoster</em> — assume ocular involvement if lesions are present on the tip of the nose (Hutchinson's sign).</li></ul></li><li>Soft contact lens use with corneal symptoms (such as photophobia and watering).</li></ul></li><li>Associated symptoms such as:<ul><li>Nasal congestion, nasal itch, rhinorrhoea and sneezing.</li><li>Upper respiratory tract infection.</li><li>Enlarged tender lymph nodes.</li></ul></li><li>Past medical history including:<ul><li>History of atopy, allergy and similar episodes.</li><li>Immunocompromise for example HIV, chemotherapy or immunosuppressant therapy.</li><li>Systemic conditions which can present with clinical features of conjunctivitis such as rheumatoid arthritis, Sjögrens syndrome, systemic lupus erythematous, and reactive arthritis.</li><li>Ophthalmic surgery.</li></ul></li><li>Drug history including prescribed and over-the-counter mydriatics, anticholinergics and anticoagulants.</li><li>Social history including smoking, occupation, hobbies, sexual activity, and travel.</li></ul><p><strong>Examine the person assessing the:</strong></p><ul><li>Conjunctiva — look for injection, chemosis (swelling), follicles, papillae and membranes. Pull on the lower eyelid and evert the upper lid to examine the palpebral conjunctiva.<ul><li>Follicles (small yellowish elevations of lymphocytes) can be associated with adenovirus and chlamydia.</li><li>Papillae (small conjunctival elevations with central vessels) can be associated with allergic conjunctivitis and contact lens intolerance.</li><li>Conjunctival membranes (yellow/white layer of fibrin adherent to underlying conjunctival tissue) can form in severe viral or bacterial infections and cause complications such as conjunctival scarring and severe dry eye.</li></ul></li><li>Cornea – look for ulceration and opacities.<ul><li>If available, consider evaluating the cornea with a Wood lamp and fluorescein staining to identify abnormalities (for example corneal dendrites [HSV keratitis] and corneal ulcers).</li></ul></li><li>Sclera — look for localized or widespread oedema and erythema which indicates a serious cause such as scleritis.</li><li>Pupil — assess shape, size and pupillary reaction (with a pen torch) looking for asymmetric or unreactive pupils.</li><li>Visual acuity (using a Snellen chart) and visual fields. Compare to previous levels of visual acuity, if possible. </li><li>Eyelids – look for discharge, swelling, inflammation, malposition, nodules, loss of lashes (may indicate sebaceous gland carcinoma), vesicles (herpes), lice infestation or blepharitis.</li><li>Periorbital area — look for swelling and erythema which may indicate orbital or periorbital cellulitis.<ul><li>Periorbital cellulitis can develop from conjunctivitis in young children.</li><li>A dull blue discolouration below the eye sometimes called the ‘allergic shiner’ resulting from venous congestion may be present in some people with allergies.</li></ul></li><li>Lymph nodes — look for regional lymphadenopathy in the periauricular, submandibular and cervical areas (more consistent with infectious cause).</li></ul><p><strong>Investigations:</strong></p><ul><li>Investigations are not normally required.</li></ul><!-- end field ea2d6939-3424-4606-a073-206d9236f542 --><!-- end item 485c683a-6e37-4093-a68c-15b37ac7ec05 -->","topic":{"id":"b4698c45-6b7c-5244-836f-430591327957","topicId":"27f540e5-bb8e-4cee-a0aa-be515efa4fc2","topicName":"Conjunctivitis - allergic","slug":"conjunctivitis-allergic","lastRevised":"Last revised in October 2020","chapters":[{"id":"bc756208-c2a7-5b33-a4cb-67c41a75ecb0","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"6470bf56-596c-5d66-b2b2-ba79590bb255","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"17755f2a-0980-50f9-b62e-a34968c9682e","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"b1dc6613-43b4-55fe-9216-a83aab0ef918","slug":"changes","fullItemName":"Changes"},{"id":"ba5e8d6b-90f7-5b69-b09a-2bb0c2692918","slug":"update","fullItemName":"Update"}]},{"id":"fee1ca82-9d2a-50a4-9230-1a93482b8b4f","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"3d036930-da50-5ea2-82e1-1d0fb936a8b4","slug":"goals","fullItemName":"Goals"},{"id":"9ba6a0ce-0eae-5442-85f0-81f7ff71345b","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"48935dfe-bca1-53fa-8d50-fa978331bd56","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"35b962f0-ec6b-53c9-b6f2-a5783ae10716","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"8e9984f4-8c0d-5231-9eec-91a9fb49ecc4","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"8fa3b231-6e2b-5fa2-aa0c-eb5359ff8160","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"ebf46a5d-2a79-5df8-82dd-d23fcb0559f1","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"67185462-9d0a-5b7d-b8af-80b8958f2420","slug":"definition","fullItemName":"Definition"},{"id":"1c320f1a-b91f-5d5b-a47b-dc0094518883","slug":"prevalence","fullItemName":"Prevalence"},{"id":"b21baf96-f39b-5eeb-934b-c193a434933d","slug":"causes","fullItemName":"Causes"},{"id":"923b6415-5fe1-550a-baf5-89285f8ddf77","slug":"complications","fullItemName":"Complications"},{"id":"a679bff6-4749-539e-bdb0-a762a9f91728","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"a7d99d63-f47f-54bf-a60f-8ae6f2a42fb9","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"089d5cf7-0f6b-521b-88c1-d4f25eef7101","slug":"assessment","fullItemName":"Assessment"},{"id":"7bb8bdb4-0279-5783-ba21-e44e8bcd0832","slug":"clinical-features","fullItemName":"Clinical features"},{"id":"9a95dbd6-aaa4-5d6a-aa5b-9635d279f9a0","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"51e7c1d5-cd3d-5dea-a8ec-5a38deb58245","fullItemName":"Management","slug":"management","subChapters":[{"id":"e4ced49a-4b06-5559-9efb-c708812a8065","slug":"referral","fullItemName":"Scenario: Referral"},{"id":"77a507ec-4dff-5204-b375-121264b0adf8","slug":"management-in-primary-care","fullItemName":"Scenario: Management in primary care"}]},{"id":"452bc42e-1fe8-56e6-8511-57362d05fe3f","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"f9e89c16-d4a7-5241-86f6-1f78eacc68fa","slug":"topical-ocular-antihistamines-mast-cell-stabilizers","fullItemName":"Topical ocular antihistamines and mast cell stabilizers"},{"id":"f9a1678c-7117-5852-af35-628b676780c8","slug":"mast-cell-stabilizers","fullItemName":"Mast cell stabilizers"}]},{"id":"a32b7db8-1764-58b8-adbb-ab8ce0f44e46","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"bd1a2d20-e91f-51f1-a2a2-486ebf015f65","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"bc4e76de-c203-5f3e-ad9a-b84d6bc9d81e","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"565b3a01-b21e-5837-b9f1-49fda55982ad","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"b08973ef-af46-5e6f-b85c-d0bd9ca40bab","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"3003e52e-8597-505e-a3ce-e46fde4c0c20","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"b7947929-e2f9-50c7-b5cd-3e34b802bae1","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"3819cbbb-ca8c-58b7-b608-0a9567c5d5b5","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"a7d99d63-f47f-54bf-a60f-8ae6f2a42fb9","slug":"diagnosis","fullItemName":"Diagnosis"},"subChapters":[{"id":"c8d056c8-befd-5915-b4ba-117265b66a94","slug":"basis-for-recommendation-6d7","fullItemName":"Basis for recommendation","depth":3,"htmlHeader":"<!-- begin field 1e0c4123-01fe-49ec-a964-f5313d75401f --><h3>Basis for recommendation</h3><!-- end field 1e0c4123-01fe-49ec-a964-f5313d75401f -->","summary":null,"htmlStringContent":"<!-- begin item 6d70230b-92ed-4b24-9fdb-2639be12b0e4 --><!-- begin field fbd4c368-8a66-404d-9a36-72e6d2a064e4 --><p>The recommendations on assessment of a person with suspected allergic conjunctivitis are based on the clinical guidelines <em>Conjunctivitis preferred practice pattern – 2013</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/conjunctivitis-allergic/references/\">American Academy of Ophthalmology, 2013</a>] and <em>Management of infective conjunctivitis in primary care</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/conjunctivitis-allergic/references/\">RCGP, 2013</a>] and expert opinion in review articles [<a class=\"bibliography-reference internal-reference\" href=\"/topics/conjunctivitis-allergic/references/\">Azari, 2013b</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/conjunctivitis-allergic/references/\">Bielory, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/conjunctivitis-allergic/references/\">Wong, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/conjunctivitis-allergic/references/\">Alfonso, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/conjunctivitis-allergic/references/\">Drew, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/conjunctivitis-allergic/references/\">McAnena, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/conjunctivitis-allergic/references/\">Pflipsen, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/conjunctivitis-allergic/references/\">Berger, 2017</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/conjunctivitis-allergic/references/\">BMJ Best Practice, 2017a</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/conjunctivitis-allergic/references/\">BMJ Best Practice, 2017b</a>].</p><h4>Red flags</h4><ul><li>One systematic review [<a class=\"bibliography-reference internal-reference\" href=\"/topics/conjunctivitis-allergic/references/\">Narayana, 2015</a>] found that the most useful clinical features indicating serious eye disease were:<ul><li>A smaller pupil in the red eye (difference between pupil diameters greater than1 mm; likelihood ratio, 6.5; 95% CI 2.6–16.3).</li><li>Photophobia on direct illumination (likelihood ratio 8.3; 95% CI, 2.7–25.9), indirect illumination (likelihood ratio 28.8; 95% CI, 1.8–459), or ‘finger-to-nose convergence test’ (likelihood ratio 21.4; 95% CI, 12–38.2).</li></ul></li><li>Use of soft contact lenses increases the risk of infective conjunctivitis with corneal involvement — the Royal College of General Practitioners recommends routinely asking if soft contact lenses are worn [<a class=\"bibliography-reference internal-reference\" href=\"/topics/conjunctivitis-allergic/references/\">RCGP, 2013</a>].</li><li>Hyperacute presentation of conjunctivitis with copious mucopurulent discharge in a sexually active person should be considered to be <em>Neisseria gonorrhoeae</em> (GC), until proven otherwise [<a class=\"bibliography-reference internal-reference\" href=\"/topics/conjunctivitis-allergic/references/\">Azari, 2013b</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/conjunctivitis-allergic/references/\">BMJ Best Practice, 2017a</a>].</li><li>Neonatal (less than 4 weeks) sticky eye with redness must always be referred urgently to ophthalmology to prevent serious complications [<a class=\"bibliography-reference internal-reference\" href=\"/topics/conjunctivitis-allergic/references/\">RCGP, 2013</a>].</li></ul><h4>Contacts with similar symptoms</h4><ul><li>Recent exposure to infectious conjunctivitis or respiratory tract infections in the home, school, or workplace are suggestive of an infectious cause [<a class=\"bibliography-reference internal-reference\" href=\"/topics/conjunctivitis-allergic/references/\">Bielory, 2013</a>].</li></ul><h4>Over-the counter and prescribed medications</h4><ul><li>Topical ocular medications (such as preserved artificial tears or decongestants) may cause inflammation of the ocular surface. Oral medications (such as first generation antihistamines) may cause ocular dryness [<a class=\"bibliography-reference internal-reference\" href=\"/topics/conjunctivitis-allergic/references/\">Bielory, 2013</a>].</li></ul><h4>Co-existent conditions</h4><ul><li>Systemic autoimmune diseases (for example rheumatoid arthritis and Sjögren's syndrome) can present with keratoconjunctivitis sicca or dry eye.</li><li>Dry eye disease and allergic conjunctivitis often coexist — dry eye may exacerbate allergic conjunctivitis as a normal tear film is needed to dilute and remove environmental allergens from the eye surface. Lower concentrations of allergens on the eye surface are less likely to provoke an allergic response [<a class=\"bibliography-reference internal-reference\" href=\"/topics/conjunctivitis-allergic/references/\">Bielory, 2013</a>].</li></ul><!-- end field fbd4c368-8a66-404d-9a36-72e6d2a064e4 --><!-- end item 6d70230b-92ed-4b24-9fdb-2639be12b0e4 -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}